House Committee Asks FDA for More Info on Contaminated Heparin Investigations
By Zachary Brennan -
Published 15 March 2017
Four Republicans on the House Committee on Energy & Commerce sent a letter on Wednesday to US Food and Drug Administration (FDA) acting commissioner Stephen Ostroff seeking additional information on FDA’s investigations into a heparin contamination crisis from a decade ago that are now closed.
Categories: News, China, US, FDA, Crisis management, Drugs, Government affairs, Manufacturing
Tags: heparin, China heparin, House E&C, FDA investigations